パルスフィールドアブレーション市場の成長と動向分析レポート

Pulsed Field Ablation Market Size & Trends

The global pulsed field ablation market size was estimated at USD 913.1 million in 2024 and is projected to grow at a CAGR of 33.1% from 2025 to 2030.

世界のパルスフィールドアブレーション市場規模は、2024 年に 9 億 1,310 万米ドルと推定され、2025 年から 2030 年にかけて 33.1% の CAGR で成長すると予測されています。

This is driven by its promise as a safer and more effective alternative to traditional thermal ablation methods. As the global prevalence of atrial fibrillation (AF) rises, there is an increasing demand for innovative treatment options that offer fewer complications and improved outcomes.

これは、従来の熱アブレーション方法に代わる、より安全で効果的な代替手段としての期待によって推進されています。心房細動（AF）の世界的な有病率が高まるにつれ、合併症を減らし、転帰を改善する革新的な治療選択肢への需要が高まっています。

pulsed field ablation (PFA) non-thermal mechanism significantly reduces the risk of damaging surrounding tissues, a major limitation of conventional ablation techniques like radiofrequency and cryoablation. This unique advantage has led to growing interest from healthcare providers and patients, accelerating its adoption in clinical settings.

Cardiac arrhythmias, particularly atrial fibrillation (AF), are increasingly prevalent, affecting millions worldwide. AF, characterized by an irregular and often rapid heart rate, is the most common type of sustained arrhythmia, significantly raising the risk of stroke, heart failure, and other serious cardiovascular complications. As global populations age and the incidence of lifestyle-related risk factors, such as hypertension and obesity, rises, the number of AF cases continues to grow.  According to the Johnson & Johnson Services, Inc. article published in February 2024, more than 37.5 million people globally live with this condition, emphasizing its widespread impact. The risk of developing AFib is notably high; statistics reveal that about one in four adults over the age of 40 experience this arrhythmia at some point in their lives. This growing prevalence highlights the urgent need for effective management and prevention strategies.

This escalating burden has created a substantial demand for effective, minimally invasive treatment options. Traditional therapies such as antiarrhythmic drugs and catheter-based ablation have limitations, leading to an unmet need for safer, more efficient approaches. The increasing prevalence of arrhythmias is thus a key driver of market growth for advanced treatment technologies like pulsed field ablation (PFA), which offer improved safety profiles and efficacy compared to conventional methods. In February 2024, an article in The Lancet Regional Health – Europe highlighted that atrial fibrillation (AF) affects 1.5-2% of European adults, expected to rise to 9.5% in those over 65 by 2060. AF is a significant risk factor for stroke, dementia, heart failure, and premature mortality, posing challenges for the aging population and healthcare systems.

Technological advancements are a key driver of the PFA industry’s growth, as ongoing innovations enhance ablation procedures precision, safety, and efficacy. Leading medical device companies are investing heavily in the development of next-generation PFA systems, focusing on improving energy delivery, catheter design, and procedural efficiency. Innovations in catheter flexibility and the integration of real-time imaging and mapping technologies allow for more targeted and controlled ablation, reducing the risk of complications and improving patient outcomes. In October 2024, Abbott announced important advancements in its pulsed field ablation technologies for electrophysiology. The company finished enrolling participants in the VOLT-AF IDE Study aimed at evaluating the Volt PFA System and initiated the FOCALFLEX trial to test the TactiFlex Duo Ablation Catheter for treating paroxysmal atrial fibrillation. These initiatives mark significant progress for Abbott’s PFA catheters.

Regulatory approvals are critical in influencing the PFA industry, as they validate the safety and efficacy of these novel devices, paving the way for broader clinical adoption. In recent years, several PFA systems have received CE marking in Europe, allowing them to be marketed and used across the continent. These approvals are often based on positive clinical trial results that demonstrate the benefits of PFA over traditional methods, particularly in terms of reduced procedure times and fewer complications. In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, designed for persistent atrial fibrillation and atrial flutter treatment. This makes Medtronic the first company with two FDA-approved pulsed-field ablation (PFA) technologies for AFib. The Sphere-9 catheter offers flexible treatment options with its 9mm lattice tip, complementing the PulseSelect PFA System, which provides a single-shot solution for pulmonary vein isolation.

Pulsed Field Ablation Market Report Scope

Global Pulsed Field Ablation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pulsed field ablation market report based on the components, indication, end use, and region.

• Components Outlook (Revenue, USD Million, 2018 – 2030)
• Catheters
• Generators
• Indication Outlook (Revenue, USD Million, 2018 – 2030)
• Atrial Fibrillation
• Non-atrial Fibrillation
• End-use Outlook (Revenue, USD Million, 2018 – 2030)
• Inpatient Facilities
• Outpatient Facilities
• Regional Outlook (Revenue, USD Million; 2018 – 2030)
• North America

o               U.S.

o               Canada

o               Mexico

• Europe

o               UK

o               Germany

o               France

o               Italy

o               Spain

o               Norway

o               Denmark

o               Sweden

• Asia Pacific

o               Japan

o               China

o               India

o               Australia

o               South Korea

o               Thailand

• Latin America

o               Brazil

o               Argentina

• Middle East & Africa

o               South Africa

o               Saudi Arabia

o               UAE

o               Kuwait

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Segment Definitions

1.2.1. Components

1.2.2. Indication

1.2.3. End use

1.2.4. Regional Scope

1.2.5. Estimates and forecasts timeline

1.3. Research Methodology

1.4. Information Procurement

1.4.1. Purchased database

1.4.2. GVR’s internal database

1.4.3. Secondary sources

1.4.4. Primary research

1.4.5. Details of primary research

1.5. Information or Data Analysis

1.5.1. Data analysis models

1.6. Market Formulation & Validation

1.7. Model Details

1.7.1. Commodity flow analysis (Model 1)

1.7.2. Approach 1: Commodity flow approach

1.7.3. Volume price analysis (Model 2)

1.7.4. Approach 2: Volume price analysis

1.8. List of Secondary Sources

1.9. List of Primary Sources

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Components outlook

2.2.2. Indication outlook

2.2.3. End use outlook

2.3. Regional outlook

2.4. Competitive Insights

Chapter 3. Pulsed Field Ablation Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Rising prevalence of cardiac arrhythmias

3.2.1.2. Technological advancements in PFA devices

3.2.1.3. Minimally invasive nature of PFA

3.2.2. Market Restraint Analysis

3.2.2.1. High costs of PFA devices and procedures

3.2.2.2. Lack of long-term data on effectiveness and safety

3.3. Pulsed Field Ablation Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.1.1. Bargaining power of suppliers

3.3.1.2. Bargaining power of buyers

3.3.1.3. Threat of substitutes

3.3.1.4. Threat of new entrants

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Economic landscape

3.3.2.3. Social landscape

3.3.2.4. Technological landscape

3.3.2.5. Environmental landscape

3.3.2.6. Legal landscape

Chapter 4. Pulsed Field Ablation Market: Components Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. Pulsed Field Ablation Market: Components Movement Analysis

4.3. Pulsed Field Ablation Market by Components Outlook (USD Million)

4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

4.5. Catheters

4.5.1. Catheters Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

4.6. Generators

4.6.1. Generators Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 5. Pulsed Field Ablation Market: Indication Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. Pulsed Field Ablation Market: Indication Movement Analysis

5.3. Pulsed Field Ablation Market by Indication Outlook (USD Million)

5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

5.5. Atrial Fibrillation

5.5.1. Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

5.6. Non-Atrial Fibrillation

5.6.1. Non-Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 6. Pulsed Field Ablation Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. Pulsed Field Ablation Market: End Use Movement Analysis

6.3. Pulsed Field Ablation Market by End Use Outlook (USD Million)

6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

6.5. Inpatient Facilities

6.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

6.6. Outpatient Facilities

6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 7. Pulsed Field Ablation Market: Regional Estimates & Trend Analysis

7.1. Regional Dashboard

7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030

7.3. North America

7.3.1. U.S.

7.3.1.1. Key country dynamics

7.3.1.2. Regulatory framework/ reimbursement structure

7.3.1.3. Competitive scenario

7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)

7.3.2. Canada

7.3.2.1. Key country dynamics

7.3.2.2. Regulatory framework/ reimbursement structure

7.3.2.3. Competitive scenario

7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)

7.3.3. Mexico

7.3.3.1. Key country dynamics

7.3.3.2. Regulatory framework/ reimbursement structure

7.3.3.3. Competitive scenario

7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)

7.4. Europe

7.4.1. UK

7.4.1.1. Key country dynamics

7.4.1.2. Regulatory framework/ reimbursement structure

7.4.1.3. Competitive scenario

7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)

7.4.2. Germany

7.4.2.1. Key country dynamics

7.4.2.2. Regulatory framework/ reimbursement structure

7.4.2.3. Competitive scenario

7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)

7.4.3. France

7.4.3.1. Key country dynamics

7.4.3.2. Regulatory framework/ reimbursement structure

7.4.3.3. Competitive scenario

7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)

7.4.4. Italy

7.4.4.1. Key country dynamics

7.4.4.2. Regulatory framework/ reimbursement structure

7.4.4.3. Competitive scenario

7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)

7.4.5. Spain

7.4.5.1. Key country dynamics

7.4.5.2. Regulatory framework/ reimbursement structure

7.4.5.3. Competitive scenario

7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)

7.4.6. Norway

7.4.6.1. Key country dynamics

7.4.6.2. Regulatory framework/ reimbursement structure

7.4.6.3. Competitive scenario

7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)

7.4.7. Sweden

7.4.7.1. Key country dynamics

7.4.7.2. Regulatory framework/ reimbursement structure

7.4.7.3. Competitive scenario

7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)

7.4.8. Denmark

7.4.8.1. Key country dynamics

7.4.8.2. Regulatory framework/ reimbursement structure

7.4.8.3. Competitive scenario

7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)

7.5. Asia Pacific

7.5.1. Japan

7.5.1.1. Key country dynamics

7.5.1.2. Regulatory framework/ reimbursement structure

7.5.1.3. Competitive scenario

7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)

7.5.2. China

7.5.2.1. Key country dynamics

7.5.2.2. Regulatory framework/ reimbursement structure

7.5.2.3. Competitive scenario

7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

7.5.3. India

7.5.3.1. Key country dynamics

7.5.3.2. Regulatory framework/ reimbursement structure

7.5.3.3. Competitive scenario

7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)

7.5.4. Australia

7.5.4.1. Key country dynamics

7.5.4.2. Regulatory framework/ reimbursement structure

7.5.4.3. Competitive scenario

7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)

7.5.5. South Korea

7.5.5.1. Key country dynamics

7.5.5.2. Regulatory framework/ reimbursement structure

7.5.5.3. Competitive scenario

7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)

7.5.6. Thailand

7.5.6.1. Key country dynamics

7.5.6.2. Regulatory framework/ reimbursement structure

7.5.6.3. Competitive scenario

7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)

7.6. Latin America

7.6.1. Brazil

7.6.1.1. Key country dynamics

7.6.1.2. Regulatory framework/ reimbursement structure

7.6.1.3. Competitive scenario

7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)

7.6.2. Argentina

7.6.2.1. Key country dynamics

7.6.2.2. Regulatory framework/ reimbursement structure

7.6.2.3. Competitive scenario

7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)

7.7. MEA

7.7.1. South Africa

7.7.1.1. Key country dynamics

7.7.1.2. Regulatory framework/ reimbursement structure

7.7.1.3. Competitive scenario

7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)

7.7.2. Saudi Arabia

7.7.2.1. Key country dynamics

7.7.2.2. Regulatory framework/ reimbursement structure

7.7.2.3. Competitive scenario

7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)

7.7.3. UAE

7.7.3.1. Key country dynamics

7.7.3.2. Regulatory framework/ reimbursement structure

7.7.3.3. Competitive scenario

7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)

7.7.4. Kuwait

7.7.4.1. Key country dynamics

7.7.4.2. Regulatory framework/ reimbursement structure

7.7.4.3. Competitive scenario

7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization

8.2. Key Company Profiles

8.2.1. Boston Scientific Corporation

8.2.1.1. Company overview

8.2.1.2. Financial performance

8.2.1.3. Product benchmarking

8.2.1.4. Strategic initiatives

8.2.2. Abbott

8.2.2.1. Company overview

8.2.2.2. Financial performance

8.2.2.3. Product benchmarking

8.2.2.4. Strategic initiatives

8.2.3. Medtronic

8.2.3.1. Company overview

8.2.3.2. Financial performance

8.2.3.3. Product benchmarking

8.2.3.4. Strategic initiatives

8.2.4. Biosense Webster, Inc. (Johnson & Johnson Services, Inc)

8.2.4.1. Company overview

8.2.4.2. Financial performance

8.2.4.3. Product benchmarking

8.2.4.4. Strategic initiatives

8.2.5. Pulse Biosciences, Inc

8.2.5.1. Company overview

8.2.5.2. Financial performance

8.2.5.3. Product benchmarking

8.2.5.4. Strategic initiatives

8.2.6. Kardium

8.2.6.1. Company overview

8.2.6.2. Financial performance

8.2.6.3. Product benchmarking

8.2.6.4. Strategic initiatives

8.2.7. Jia Jing Electronic Co., Ltd.

8.2.7.1. Company overview

8.2.7.2. Financial performance

8.2.7.3. Product benchmarking

8.2.7.4. Strategic initiatives

8.2.8. Adagio Medical Inc

8.2.8.1. Company overview

8.2.8.2. Financial performance

8.2.8.3. Product benchmarking

8.2.8.4. Strategic initiatives

8.2.9. CardioFocus

8.2.9.1. Company overview

8.2.9.2. Financial performance

8.2.9.3. Product benchmarking

8.2.9.4. Strategic initiatives

8.2.10. Acutus Medical, Inc

8.2.10.1. Company overview

8.2.10.2. Financial performance

8.2.10.3. Product benchmarking

8.2.10.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources

Table 2 List of Abbreviations

Table 3 Global pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 4 Global pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 5 Global pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 6 North America pulsed field ablation market, by region, 2018 – 2030 (USD Million)

Table 7 North America pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 8 North America pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 9 North America pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 10 U.S pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 11 U.S pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 12 U.S pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 13 Canada pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 14 Canada pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 15 Canada pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 16 Mexico pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 17 Mexico pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 18 Mexico pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 19 Europe pulsed field ablation market, by country, 2018 – 2030 (USD Million)

Table 20 Europe pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 21 Europe pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 22 Europe pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 23 UK pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 24 UK pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 25 UK pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 26 Germany pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 27 Germany pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 28 Germany pulsed field ablation market, by end use 2018 – 2030 (USD Million)

Table 29 France pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 30 France pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 31 France pulsed field ablation market, by end use 2018 – 2030 (USD Million)

Table 32 Italy pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 33 Italy pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 34 Italy pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 35 Spain pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 36 Spain pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 37 Spain pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 38 Denmark pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 39 Denmark pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 40 Denmark pulsed field ablation market, by end use 2018 – 2030 (USD Million)

Table 41 Norway pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 42 Norway pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 43 Norway pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 44 Sweden pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 45 Sweden pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 46 Sweden pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 47 Asia Pacific pulsed field ablation market, by country, 2018 – 2030 (USD Million)

Table 48 Asia Pacific pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 49 Asia Pacific pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 50 Asia Pacific pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 51 Japan pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 52 Japan pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 53 Japan pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 54 China pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 55 China pulsed field ablation market, by indication 2018 – 2030 (USD Million)

Table 56 China pulsed field ablation market, by end use 2018 – 2030 (USD Million)

Table 57 India pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 58 India pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 59 India pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 60 Australia pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 61 Australia pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 62 Australia pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 63 South Korea pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 64 South Korea pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 65 South Korea pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 66 Thailand pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 67 Thailand pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 68 Thailand pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 69 Latin America pulsed field ablation market, by country, 2018 – 2030 (USD Million)

Table 70 Latin America pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 71 Latin America pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 72 Latin America pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 73 Brazil pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 74 Brazil pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 75 Brazil pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 76 Argentina pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 77 Argentina pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 78 Argentina pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 79 Middle East & Africa pulsed field ablation market, by country, 2018 – 2030 (USD Million)

Table 80 Middle East & Africa pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 81 Middle East & Africa pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 82 Middle East & Africa pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 83 South Africa pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 84 South Africa pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 85 South Africa pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 86 Saudi Arabia pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 87 Saudi Arabia pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 88 Saudi Arabia pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 89 UAE pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 90 UAE pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 91 UAE pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

Table 92 Kuwait pulsed field ablation market, by components, 2018 – 2030 (USD Million)

Table 93 Kuwait pulsed field ablation market, by indication, 2018 – 2030 (USD Million)

Table 94 Kuwait pulsed field ablation market, by end use, 2018 – 2030 (USD Million)

List of Figures

Fig. 1 Information procurement

Fig. 2 Primary research pattern

Fig. 3 Market research approaches

Fig. 4 Market formulation & validation

Fig. 5 Pulsed field ablation market segmentation

Fig. 6 Market driver analysis (current & future impact)

Fig. 7 Market restraint analysis (current & future impact)

Fig. 8 SWOT analysis, by factor (political & legal, economic and technological)

Fig. 9 Porter’s five forces analysis

Fig. 10 Pulsed field ablation market, components outlook key takeaways (USD Million)

Fig. 11 Pulsed field ablation market: components movement analysis (USD Million), 2024 & 2030

Fig. 12 Catheters market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 13 Generators market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 14 Pulsed field ablation market, indication outlook key takeaways (USD Million)

Fig. 15 Pulsed field ablation market: indication movement analysis (USD Million), 2024 & 2030

Fig. 16 Atrial fibrillation market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 17 Non-atrial fibrillation market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 18 Pulsed field ablation market, end use outlook key takeaways (USD Million)

Fig. 19 Pulsed field ablation market: end use movement analysis (USD Million), 2024 & 2030

Fig. 20 Inpatient facilities market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 21 Outpatient facilities market revenue estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 22 Pulsed field ablation market: regional key takeaways (USD Million)

Fig. 23 Pulsed field ablation market: regional outlook, 2024 & 2030, USD Million

Fig. 24 North America pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 25 US pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 26 Canada pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 27 Mexico pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 28 Europe pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 29 UK pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 30 Germany pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 31 France pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 32 Spain pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 33 Italy pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 34 Norway pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 35 Denmark pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 36 Sweden pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 37 Asia Pacific pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 38 China pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 39 Japan pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 40 India pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 41 South Korea pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 42 Australia pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 43 Thailand pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 44 Latin America pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 45 Brazil pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 46 Argentina pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 47 Middle East and Africa pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 48 South Africa pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 49 Saudi Arabia pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 50 UAE pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 51 Kuwait pulsed field ablation market estimates and forecasts, 2018 – 2030 (USD Million)

Fig. 52 List of key emerging company’s/indication disruptors/innovators

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧